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Protocols for disease classification from mass
spectrometry data
We report our results in classifying protein matrix-assisted laser desorption/ionization-
time of flight mass spectra obtained from serum samples into diseased and healthy
groups. We discuss in detail five of the steps in preprocessing the mass spectral data
for biomarker discovery, as well as our criterion for choosing a small set of peaks for
classifying the samples. Cross-validation studies with four selected proteins yielded
misclassification rates in the 10–15% range for all the classification methods. Three
of these proteins or protein fragments are down-regulated and one up-regulated in
lung cancer, the disease under consideration in this data set. When cross-validation
studies are performed, care must be taken to ensure that the test set does not influ-
ence the choice of the peaks used in the classification. Misclassification rates are
lower when both the training and test sets are used to select the peaks used in classi-
fication versus when only the training set is used. This expectation was validated for
various statistical discrimination methods when thirteen peaks were used in cross-vali-
dation studies. One particular classification method, a linear support vector machine,
exhibited especially robust performance when the number of peaks was varied from
four to thirteen, and when the peaks were selected from the training set alone. Experi-
ments with the samples randomly assigned to the two classes confirmed that misclas-
sification rates were significantly higher in such cases than those observed with the
true data. This indicates that our findings are indeed significant. We found closely
matching masses in a database for protein expression in lung cancer for three of the
four proteins we used to classify lung cancer. Data from additional samples, increased
experience with the performance of various preprocessing techniques, and affirmation
of the biological roles of the proteins that help in classification, will strengthen our con-
clusions in the future.
Keywords: Biomarker discovery / Discrimination methods / Matrix-assisted laser desorption/ioni-
zation-time of flight mass spectrometry / Support vector machines PRO 0519
1 Introduction
We report results on the second challenge problem pro-
vided for the First Annual Proteomics Datamining Confer-
ence, organized by the Departments of Radiology and
Biostatistics at Duke University in September 2002. We
discuss the preprocessing techniques employed on the
mass spectra to obtain data amenable for classification,
and we assess the significance of the classification
results obtained using several algorithms. The data con-
sist of protein mass spectra obtained from serum sam-
ples of 41 individuals, 24 of whom have been diagnosed
with a disease (revealed at the conference to be lung can-
cer), and 17 healthy individuals. Each sample was further
split into twenty fractions that were obtained by varying
the pH during sample preparation. The challenge ques-
tion was: Is it possible to find patterns among the protein
mass spectra of these samples that characterize and dis-
tinguish healthy individuals from those with diesease? An
affirmative answer could lead to a potential diagnosis
tool; additionally, the identification of proteins with differ-
ent expression levels in diseased and healthy samples
provide valuable insight into the pathways that underlie
the disease in question. We were provided with the raw
data sets as well as a processed set which contained the
locations and (raw) intensities of peaks as identified by
the software that comes with the MALDI-TOF instrument.
At the conference we presented classification results from
the processed data; in this paper we present results on
the raw data, since we wish to study the influence of pre-
processing on the classification results.
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Preprocessing of the data is of crucial importance and
significantly influences the quality of the classification
results. Figure 1 illustrates the many steps involved in bio-
marker discovery beginning with the mass spectra. Each
preprocessing step allows for a number of different
options, and only with a thorough understanding of the
experimental setup, the preprocessing methods and the
significance of the output from the mass spectrometry
instrument can one hope to generate meaningful classi-
fiers. We will briefly mention the choices we made in the
next few sections. There is no consensus in the literature
about how the various preprocessing steps should be
done. The hope remains that if a strong signal is truly pre-
sent in the given data, then it will not be too sensitive to
the details of the preprocessing, and information critical
for building models with strong prediction capabilities
will be retained. Our findings should be considered tenta-
tive for this reason. With more experience, the preproces-
sing methods will improve in sophistication and robust-
ness. Biological insight (i.e., identification of the proteins
whose peaks we used in our classification) will help vali-
date our choices; until then we want to explore and
expose the options at hand, and provide a framework
useful for diseases to be classified using protein profiles
obtained through MS. A recent discussion of the role of
MALDI-TOF MS in proteomics is included in [1].
2 Materials and methods
In order to make the data amenable to classification, we
need to transform the mass spectra of each fraction (a
total of 820) into vectors, preferably of low dimension,
that characterize the samples (the peak profiles). Each
raw spectrum consists of 60 831 intensity measurements
at discrete mass/charge (m/z) values. Given the small
sample size of 41, our first goal is to reduce this data to,
say, less than twenty peaks that discriminate between
healthy and diseased states.
2.1 Baseline identification and subtraction
Each mass spectrum exhitits a base intensity level (a
baseline) which varies from fraction to fraction and conse-
quently needs to be identified and subtracted. This noise
varies across the m/z axis, and it generally varies across
different fractions, so that a one-value-fits-all strategy
cannot be applied. Figure 2 shows a sample spectrum
from the dataset. We see a near-exponential decay in the
noise at the beginning, after which the noise level appears
to be a linear function of the m/z. The picture is very simi-
lar (but not identical) for other samples. Our goal was to
get a rough approximation of the baseline, and we used
local linear regression (as implemented in the SAS soft-
Figure 1. An overview of the
various steps involved in bio-
marker discovery using mass
spectrometry. For simplicity we
have omitted the processing of
fractions in the current data set.
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Figure 2. Sample protein mass
spectrum (fraction 10 from sam-
ple A01) with baseline identified.
Table 1. Smoothing parameters used in local linear regression for baseline identification.
m/z (kDa/z) 1.7–2.3 2.3–3.7 3.7–10 10–15 15–40 40–60 60–100 100–205
smoothing parameter 1% 2% 5% 10% 20% 40% 50% 70%
ware package (SAS Institute, VA, USA) by the LOESS
procedure) iteratively in order to smooth over the peaks.
To deal with the exponential decay at the beginning we
used varying degrees of smoothness, depending on the
m/z interval being considered. A few attempts, validated
by visual inspection of a few samples, yielded the choice
of parameters tabulated in Table 1.
A look at the processed dataset (and insight gained from
the discussion at the conference) revealed that peaks
with m/z under 1.7 kDa were deemed to either stem from
matrix molecules or contaminants, so we chose to ignore
them. A second iteration of smoothing was applied by
identifying intensity values which deviated from the base-
line by more than one standard deviation. Those values
were (temporarily) replaced by their corresponding base-
line values, and the smoothing technique was re-applied.
As can be seen in the example in Fig. 2, the resulting
baseline appears to be satisfactory. Future work will
explore alternative techniques for this step.
2.2 Peak identification and extraction
The problem of identifying peaks in a mass spectrum is a
central one that deserves careful consideration. However,
in order to be able to directly compare with the processed
data given to us, we took the masses of the peaks from
the processed data; these were identified by the software
provided with the mass spectrometry instrument,
coupled with some human processing. We noticed that
the peak locations provided in the processed data did
not always quite correspond to local maxima in our base-
line-corrected mass spectrum, and so we took the mass
location and intensity of the local maximum within thirty
measurement points of the peak mass from the pro-
cessed data. In rare cases this resulted in peak intensities
that were negative (i.e., the “peak” lies beneath the com-
puted baseline). Visual inspection of several such exam-
ples revealed that the intensities at these points were not
really distinguishable as peaks, and so we deemed it safe
to ignore these rare cases. Future versions of our proces-
sing strategy will incorporate a custom peak identification
procedure based on the distribution of intensities, taking
advantage of the fact that peak intensities correspond to
points in the tail of the overall distribution of intensities.
2.3 Intensity normalization
Details of the experimental setup are such that the abso-
lute peak intensities are not comparable across different
fractions, let alone samples. This motivates the need for a
normalization scheme which ultimately enables the mer-
ging of the peak profile of fractions into a peak profile of a
sample. One could think of a number of choices of how to
normalize: with respect to the maximum intensity in a
sample, using the sum of all peak intensities, or, possibly,
using the total area under the peaks as reference value.
None of these is an obvious choice, and all have severe
defects in the presence of pathological examples. After
some discussion we chose to normalize with respect to
the sum of the intensities. And so each peak intensity
was divided by the sum of all peak intensities in that frac-
tion and multiplied by 1000, so that the processed inten-
sities could be interpreted over a uniform range across
fractions and samples.
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2.4 Merger of fraction data into sample data
There are numerous cases where several fractions display
peaks at very similar mass points, and so the question
arises how to decide when two peaks in different fractions
are to be considered to stem from the same protein and
when they represent different proteins. In order to extract
a single peak profile per sample one needs to merge the
normalized peak profiles from the twenty fractions. The
mass accuracy of the instrument was given to be approx-
imately 0.1%. We chose the following heuristic when mer-
ging peaks: If the masses of two peaks are within 0.2%,
we merge them and assign the new peak to have a mass
of the average of the two and its intensity to be the max-
imum of the two peaks. The tolerance of 0.2% was inten-
tionally chosen to be larger than the instrument accuracy
to additionally smooth the data. This scheme was applied
iteratively, with subsequent new peak masses to be cho-
sen as the weighted average of the previous peaks.
2.5 Peak alignment across samples
Finally, in order to make the peak profiles comparable
across different samples, we need to align them, i.e., to
find one common set of peak locations across all samples
that will work as coordinates for the vectors we will use for
each sample in the classification schemes to follow. The
idea we used is identical to the one used when merging
fractions into samples: if two peaks are within 0.2% of
each other then they will be considered identical and their
masses are reassigned.
2.6 Peak selection
The preceding steps result in vectors of length 603 for
each sample which we now take to characterize the sam-
ples. Of the 603 peaks in this reduced dataset, over 60%
appear in only very few samples and are thus not likely
to be helpful in classifying the majority of the samples.
Hence we chose to ignore any peaks that occurred in
fewer than eight samples, a step which reduced the di-
mension of the identifying vectors down to 229. There is
no hope of getting statistically significant results if the
number of data points is less than the degrees of free-
dom, so we need to further reduce the number of peaks
used in the classification. We ordered the peaks accord-
ing to their information content as measured by the F-sta-
tistic. This is equivalent to computing the ratio of var-
iances of peak intensities between and within the two
groups (B/W ratio) and sorting in decreasing order. A simi-
lar technique has been used in classifying cancers using
gene expression data, where it is called gene selection
[2]. We subsequently experimented with the classification
algorithms using between three and fifteen peaks as
ordered by the B/W criterion. The questions we address
now are: Can we, after these carefully chosen but admit-
tedly still rather ad hoc preprocessing steps, identify
peaks corresponding to biomarkers that are fundamen-
tally affected by the disease? Furthermore, is it possible
to assess the confidence of our prediction?
3 Results and discussion
We report classification results using established statisti-
cal and optimization-based tools: linear discrimination,
quadratic discrimination, nonparametric discrimination
using a kernel, nonparametric discrimination using k-near-
est neighbor classification (kNN) using the Mahalanobis
distance, and linear support vector machines (SVM). We
do not give detailed descriptions of these classification
methods here due to space considerations, but refer the
interested reader to the excellent discussions of these
methods in [3, 4].
We implemented the entire scheme from Fig. 1 using a
combination of languages and tools such as Perl, SAS
and Matlab (Mathworks, Natick, MA, USA). The SVMlight
software [5] was used for the support vector machine.
Some of these methods require an a priori choice of pa-
rameters, in particular we chose k = 6 for kNN, r = 0.5 for
the kernel method and C = 1, where C is the tradeoff pa-
rameter between margin maximization and misclassifica-
tion error in the SVM. We stress that we did not perform
extensive parameter tuning experiments here. A common
practice from both the statistics and machine learning lit-
eratures is to use cross-validation to test the power and
quality of the methods. The data set is split into a training
set, which is given to the classification method in order to
build the model, and a test set, which is used to assess
the quality of the model. The rather small size of the data-
set (41 samples) constrains us to perform only a leave-
one-out cross-validation test. Here 40 samples are used
as training set and the remaining one is used as test sam-
ple. This is done until each of the 41 samples has been left
out, and we report on the overall classification results.
We examined two cases, one where the peak selection
(using B/W ratios) is performed on the entire dataset
(“preselected peaks”), and another where peaks are rese-
lected for each training set. The former biases the peak
selection using information from the test set and, as
such, is not quite a fair test of the generalization capabil-
ities of the models. Consequently, one would expect the
second validation test to be more stringent and to predict
higher and more realistic error rates. In the case of prese-
lected peaks, information such as covariance structure
required by kNN and the nonparametric kernel method is
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also computed using the entire dataset, which further
biases the classification. This is what is done by default
in packages such as SAS, and as we will see it has dra-
matic consequences. Finally, we ran all the methods with
various numbers of selected peaks, keeping in mind that
results obtained with a smaller number of peaks are likely
to be more robust. We present results for four and thirteen
peaks selected using the B/W ratio.
Table 2 shows leave-one-out cross-validation results for
the top four selected peaks. Here and in future tables,
group A corresponds to lung cancer samples and group
B to samples from healthy individuals. We see that, for
example, the quadratic discrimination method misclassi-
fies four samples from group A as belonging to group B,
and one sample from B as belonging to A, the overall
error rate is thus 12%. The results are (with one excep-
tion) identical for preselected and reselected peaks,
since these four peaks consistently rank as the top four
using the B/W criterion (although they do change order
sometimes when reselecting during cross-validation).
The only exception is kNN which classifies one addition-
al sample from B correctly in the case of preselected
peaks. The reason this occurs (despite using the same
features) is that kNN uses covariance information in cal-
culating the Mahalanobis distance, which in this case is
based on the entire dataset, not just a subset of forty
samples. Tables 3 and 4 show the behavior of the meth-
Table 2. Leave-one-out cross-calidation results using the top four peaks selected from a total of 229
Method From To Error Method From To Error
A B rate (%) A B rate (%)
Lin. Discrim. A 22 2 10 Quad. Discrim. A 20 4 12
B 2 15 B 1 16
Nonpar. Kernel A 20 4 12 kNN A 21 3 15
B 1 16 B 3 14
Linear SVM A 22 2 15
B 4 13
Table 3. Leave-one-out cross-validation results using the top thirteen peaks, with reselection in
every iteration
Method From To Error Method From To Error
A B rate (%) A B rate (%)
Lin. Discrim. A 18 6 27 Quad. Discrim. A 20 4 34
B 5 12 B 10 7
Nonpar. Kernel A 22 2 29 kNN A 18 6 27
B 10 7 B 5 12
Linear SVM A 23 1 2
B 0 17
Table 4. Leave-one-out cross-validation results using the top thirteen peaks selected using the
entire dataset
Method From To Error Method From To Error
A B rate (%) A B rate (%)
Lin. Discrim. A 22 2 12 Quad. Discrim. A 22 2 24
B 3 14 B 8 9
Nonpar. Kernel A 24 0 7 kNN A 24 0 0
B 3 14 B 0 17
Linear SVM A 23 1 2
B 0 17
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ods for thirteen peaks; in one case the peaks were
selected using the entire dataset, and in the other we
reselected them in every cross-validation step using only
the training set.
Fisher’s linear discrimination assumes homogeneous
covariance matrices for the two groups, and uses a
pooled sample covariance matrix for the construction of
the discriminant functions. For the current data set we
have observed that the covariance matrices are not ho-
mogeneous. This explains the poor performance of this
method in general. kNN is a local method which can pro-
duce poor results for noisy data in general. However, both
fared well when only four peaks were used. It is interesting
to note in this case that the four selected peaks were the
same whether the F-statistic (B/W ratio) is calculated
using the pooled sample variance or using the weighted
form of the sample variance (to account for the heteroge-
neity of the variances). Hence the performance of these
methods is comparable to those that account for the dif-
ference in the covariance matrices.
The quadratic discrimination and nonparametric kernel
methods account for the heterogeneity of the covariance
matrices by using different covariance matrices for differ-
ent groups in the construction of the discriminant func-
tions.
However, the small sample sizes (only 17 samples for
group B) in the current data set cause these covariance
matrices to become nearly singular when a large number
of peaks are used. This explains the poor performance of
these methods when thirteen peaks are used for classifi-
cation. It is interesting to note however that the SVM is
apparently not affected by these drawbacks and fared
well in all these situations. It seems to be significantly
more robust in terms of performance with varying num-
bers of peaks. We also see that, as expected, the error
rates are generally higher when the peak selection is
based only on information in the training set. Again, the
SVM is a notable exception.
To assess the significance of the results presented in the
previous section we ran again our methods on the same
data but with randomized group assignments. That is,
while the peak profile vectors were kept the same, the
assignment to groups A and B were randomized. The
ratio of the numbers of samples in the two groups was
kept at 24/17, as in the original data set. The purpose of
this is to attempt to get insight into how significant the
classification results are by comparing them to results on
what essentially is random data of a similar nature. The
corresponding results are presented in Table 5. We show
the average leave-one-out error rate as well as the best
and worst errors. These results provide a benchmark to
the results in Table 2. They illustrate that the latter seem
to be significant and not artifacts of the choices made in
the preprocessing stages.
The masses of the four most significant peaks that we
used to distinguish between cancerous samples and
healthy samples (for the results reported in Table 2) are
tabulated in Table 6. The first, third, and fourth of these
peaks are down-regulated in lung cancer, while the sec-
ond is up-regulated; indeed, the second peak appears
Table 5. Error rates for cross-calidation runs on ten datasets generated from original data by random-
izing the group assignments. Four peaks with reselection were used





54 (37, 86) 48 (22, 80) 48 (27, 83) 52 (29, 73) 49 (24, 76)
Table 6. The masses of the four proteins used to classify lung cancer in this paper, and their matches
with proteins from a database for lung cancer protein expression. Two close matches were
found for the second protein, and no match was found for the fourth protein
Suggested peak Change in cancer Reported peak Description of protein
28 088.9 down 27 774 Stratifin
11 858 Cellurar retinoic acid binding protein
11 695.2 up 11 521 Protein kinase C inhibitor
9 481.7 down 9 200 Cytochrome c oxidase
8 712.4 down NA NA
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only in one of the healthy samples, at a low intensity. We
compared these protein masses with a database of pro-
tein expression in lung cancer [6] to find matching pro-
teins with close masses. Three of the four proteins we
have employed for classification have closely matching
proteins, as shown in Table 6. Of these, the stratifin and
cellular retinoic acid binding protein are differentially
expressed in small cell, adenocarcinoma, and squamous
lung tumors. These matches should be considered tenta-
tive at this stage until the proteins in our study are
sequenced and identified. Identifying these proteins or
protein fragments and understanding their role in lung
cancer would provide credence to the data processing
techniques and classification algorithms that we have
employed.
4 Concluding remarks
We have discussed in detail five of the steps in preproces-
sing the mass spectral data for biomarker discovery, as
well as our criterion for choosing a small set of peaks for
classifying the samples. Cross-validation studies with
four proteins with the highest B/W ratio yielded misclassi-
fication rates in the 10–15% range for all the classification
methods. Three of these proteins or protein fragments are
down-regulated and one up-regulated in lung cancer.
When cross-validation studies are performed, care must
be taken to ensure that the test set does not influence the
choice of the peaks used in the classification. Unfortu-
nately, statistical packages do not guarantee this when
default settings in their methods are employed. Misclassi-
fication rates are generally lower when both the training
and test sets are used to select the peaks used in classi-
fication, than when only the training set is used. This
expectation was dramatically borne out when thirteen
peaks were used in cross-validation studies. However,
when only four peaks were used to classify, the two
approaches led to almost identical results; this was due
to the fact that in these cases, the identity of the four
peaks did not change when the training set changed. We
take this as another strong indication that these four
peaks are indeed good candidates for biomarkers.
Experiments with the samples randomly assigned to the
two classes confirmed that misclassification rates were
higher in such cases than those observed with the true
data. We strongly believe that stringent validation experi-
ments of this or similar nature should always be per-
formed when dealing with high-dimensional data. The
group covariance matrices were heterogeneous for the
lung cancer and healthy groups, leading to poor expected
performances for linear discrimination and nearest neigh-
bor classification. Quadratic discrimination and non-
parametric kernel discrimination methods account for
the heterogeneity in the data, but suffered from the near
singularity of the covariance matrices when the number of
peaks used to classify was large relative to the number of
samples in a group. The support vector machine exhib-
ited robust performance when the number of peaks was
varied from four to thirteen, and when the peaks were
selected from the training set alone. Three of the four pro-
teins we used in classifying lung cancer have closely
matching proteins in a protein expression database for
lung cancer.
We caution that the number of samples included in this
study was small, and that our conclusions should be con-
sidered tentative for this reason. Data from additional
samples, increased experience with the performance of
various preprocessing techniques, and more insight into
both the experimental setup and the underlying biology
of the disease will strengthen our methodology in the
future.
A part of the third author’s work was done while he was
visiting the Computer Science Research Institute at San-
dia National Labs, Albuquerque NM.
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